Nanomedz Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 15.33%
- Profit Growth 81.50%
- Ebitda -2.48%
- Net Worth -1.06%
- Total Assets 63.10%
About Nanomedz Health Sciences
Nanomedz Health Sciences Private Limited (NHSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 10 November 2017 (Seven years and three months 4 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rathindra Mitra and Somenath Mitra serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74994WB2017PTC223418
-
Company No.
223418
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Nov 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Nanomedz Health Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somenath Mitra
|
Director | 10-Nov-2017 | Current |
|
Rathindra Mitra
|
Director | 10-Nov-2017 | Current |
Financial Performance of Nanomedz Health Sciences.
Nanomedz Health Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.33% increase. The company also saw a substantial improvement in profitability, with a 81.5% increase in profit. The company's net worth dipped by a decrease of 1.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nanomedz Health Sciences?
Unlock access to Nanomedz Health Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nanomedz Health Sciences?
Unlock and access historical data on people associated with Nanomedz Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nanomedz Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nanomedz Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.